Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 713,000 | 340,200 | 264,000 | 194,100 | 233,000 |
| Marketable Securities | 767,400 | 774,600 | 711,600 | 749,400 | 843,100 |
| Receivables | 686,800 | 728,000 | 595,700 | 516,000 | 479,100 |
| Inventories | 69,000 | 69,300 | 56,900 | 59,100 | 57,400 |
| Other current assets | 115,800 | 68,200 | 120,700 | 119,300 | 63,600 |
| TOTAL | $2,522,700 | $2,158,400 | $1,748,900 | $1,637,900 | $1,724,700 |
| Non-Current Assets | |||||
| PPE Net | 89,800 | 97,300 | 91,700 | 87,000 | 82,600 |
| Investments And Advances | 1,183,800 | 1,116,600 | 961,300 | 909,500 | 864,300 |
| Intangibles | 0 | 35,700 | 37,200 | 36,400 | 0 |
| Other Non-Current Assets | 835,200 | 857,700 | 1,050,700 | 1,016,900 | 1,047,100 |
| TOTAL | $2,108,800 | $2,107,300 | $2,140,900 | $2,049,800 | $1,994,000 |
| Total Assets | $4,631,500 | $4,265,700 | $3,889,800 | $3,687,700 | $3,718,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 674,300 | 584,300 | 489,500 | 475,200 | 461,600 |
| Other current liabilities | 69,100 | 53,700 | 56,800 | 47,700 | 46,100 |
| TOTAL | $743,400 | $638,000 | $546,300 | $522,900 | $507,700 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 635,000 | 624,100 | 649,200 | 629,100 | 621,300 |
| TOTAL | $635,000 | $624,100 | $649,200 | $629,100 | $621,300 |
| Total Liabilities | $1,378,400 | $1,262,100 | $1,195,500 | $1,152,000 | $1,129,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,364 | 99,706 | 99,182 | 98,966 | 99,704 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 447,700 | 294,000 | 84,500 | -5,300 | 29,200 |
| Other shareholders' equity | 13,100 | 13,200 | 12,500 | 9,000 | 5,800 |
| TOTAL | $3,253,100 | $3,003,600 | $2,694,300 | $2,535,700 | $2,589,700 |
| Total Liabilities And Equity | $4,631,500 | $4,265,700 | $3,889,800 | $3,687,700 | $3,718,700 |